MEDICAIT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICAIT
Largest movements
- Receivables within one year -€17,589
down €17,589 (-39.0%), from €45,082 to €27,493
of which Trade receivables: -€22,230
- Cash +€8,840
up €8,840 (+22.0%), from €40,228 to €49,068
mainly Other debts (+€26,368) and Receivables within one year (+€17,589)
- Tangible fixed assets -€5,617
no longer reported in 2025 (was €5,617)
of which Furniture and vehicles: -€5,617
- Profit (loss) carried forward -€35,665
down €35,665 (-100%), from €35,665 to €0
- Other debts +€26,368
up €26,368 (+726%), from €3,632 to €30,000
- Tax, wage and social debts -€8,923
down €8,923 (-73.8%), from €12,097 to €3,174
of which Taxes: -€8,425
- Trade debts +€4,601
up €4,601 (+103%), from €4,451 to €9,052
- Turnover -€87,613
down €87,613 (-45.1%), from €194,285 to €106,672
- Purchases and services -€59,540
down €59,540 (-42.6%), from €139,773 to €80,233
- Gross operating margin -€28,073
down €28,073 (-51.5%), from €54,512 to €26,439
- Taxes -€9,775
down €9,775 (-97.8%), from €10,000 to €225
- Write-downs +€3,479
up €3,479 (+138%), from €2,521 to €6,000
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €90,926 | €76,561 | -€14,366 | -15.8% |
| Fixed assets | 21/28 | €5,617 | - | -€5,617 | |
| Tangible fixed assets | 22/27 | €5,617 | - | -€5,617 | |
| Plant, machinery and equipment | 23 | €0 | - | = | |
| Furniture and vehicles | 24 | €5,617 | - | -€5,617 | |
| Current assets | 29/58 | €85,310 | €76,561 | -€8,749 | -10.3% |
| Amounts receivable within one year | 40/41 | €45,082 | €27,493 | -€17,589 | -39.0% |
| Trade receivables | 40 | €42,708 | €20,477 | -€22,230 | -52.1% |
| Other amounts receivable | 41 | €2,374 | €7,016 | +€4,642 | +196% |
| Cash at bank and in hand | 54/58 | €40,228 | €49,068 | +€8,840 | +22.0% |
| Deferred charges and accrued income | 490/1 | - | €0 | = | |
| Total equity and liabilities | 10/49 | €90,926 | €76,561 | -€14,366 | -15.8% |
| Equity | 10/15 | €70,747 | €34,335 | -€36,412 | -51.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €16,482 | €15,735 | -€747 | -4.5% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €14,622 | €13,875 | -€747 | -5.1% |
| Profit (loss) carried forward | 14 | €35,665 | €0 | -€35,665 | -100% |
| Amounts payable | 17/49 | €20,180 | €42,226 | +€22,046 | +109% |
| Amounts payable within one year | 42/48 | €20,180 | €42,226 | +€22,046 | +109% |
| Trade debts | 44 | €4,451 | €9,052 | +€4,601 | +103% |
| Suppliers | 440/4 | €4,451 | €9,052 | +€4,601 | +103% |
| Taxes, remuneration and social security | 45 | €12,097 | €3,174 | -€8,923 | -73.8% |
| Taxes | 450/3 | €10,386 | €1,961 | -€8,425 | -81.1% |
| Remuneration and social security | 454/9 | €1,711 | €1,212 | -€498 | -29.1% |
| Other amounts payable | 47/48 | €3,632 | €30,000 | +€26,368 | +726% |
| Accrued charges and deferred income | 492/3 | - | €0 | = | |
| Turnover | 70 | €194,285 | €106,672 | -€87,613 | -45.1% |
| Goods, raw materials, services and sundry goods | 60/61 | €139,773 | €80,233 | -€59,540 | -42.6% |
| Remuneration, social security and pensions | 62 | €15,851 | €16,718 | +€866 | +5.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,793 | €5,617 | -€176 | -3.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €2,521 | €6,000 | +€3,479 | +138% |
| Other operating charges | 640/8 | €1,088 | €4,012 | +€2,924 | +269% |
| Gross operating margin | 9900 | €54,512 | €26,439 | -€28,073 | -51.5% |
| Operating profit (loss) | 9901 | €29,259 | -€5,908 | -€35,167 | |
| Financial income | 75/76B | €121 | €0 | -€121 | -99.9% |
| Recurring financial income | 75 | €121 | €0 | -€121 | -99.9% |
| Financial charges | 65/66B | €278 | €279 | +€2 | +0.6% |
| Recurring financial charges | 65 | €278 | €279 | +€2 | +0.6% |
| Profit (loss) for the period before taxes | 9903 | €29,102 | -€6,187 | -€35,289 | |
| Income taxes | 67/77 | €10,000 | €225 | -€9,775 | -97.8% |
| Profit (loss) for the period | 9904 | €19,102 | -€6,412 | -€25,514 | |
| Profit (loss) for the period to be appropriated | 9905 | €19,102 | -€6,412 | -€25,514 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.